Cargando…
Black tea and improvement of attention: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
Following an application from Unilever NV, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Ireland, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scienti...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009616/ https://www.ncbi.nlm.nih.gov/pubmed/32625903 http://dx.doi.org/10.2903/j.efsa.2018.5266 |
_version_ | 1783495706530545664 |
---|---|
author | Turck, Dominique Bresson, Jean‐Louis Burlingame, Barbara Dean, Tara Fairweather‐Tait, Susan Heinonen, Marina Hirsch‐Ernst, Karen Ildico Mangelsdorf, Inge McArdle, Harry J Naska, Androniki Neuhäuser‐Berthold, Monika Nowicka, Grażyna Pentieva, Kristina Sanz, Yolanda Sjödin, Anders Stern, Martin Tomé, Daniel Van Loveren, Henk Vinceti, Marco Willatts, Peter Martin, Ambroise Strain, Sean (JJ) Siani, Alfonso |
author_facet | Turck, Dominique Bresson, Jean‐Louis Burlingame, Barbara Dean, Tara Fairweather‐Tait, Susan Heinonen, Marina Hirsch‐Ernst, Karen Ildico Mangelsdorf, Inge McArdle, Harry J Naska, Androniki Neuhäuser‐Berthold, Monika Nowicka, Grażyna Pentieva, Kristina Sanz, Yolanda Sjödin, Anders Stern, Martin Tomé, Daniel Van Loveren, Henk Vinceti, Marco Willatts, Peter Martin, Ambroise Strain, Sean (JJ) Siani, Alfonso |
collection | PubMed |
description | Following an application from Unilever NV, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Ireland, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to black tea and improvement of attention. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The food proposed by the applicant as the subject of the health claim is black tea. The Panel considers that black tea characterised by its content of tea solids, caffeine and l‐theanine, which is the subject of the health claim, is sufficiently characterised in relation to the claimed effect. The claimed effect proposed by the applicant is ‘improves attention’. The Panel considers that improvement of attention is a beneficial physiological effect. Three human intervention studies provided by the applicant show an effect of black tea on attention under the conditions of used proposed by the applicant. The applicant proposed that the claimed effect depends on the concerted action of two substances, caffeine and l‐theanine, both of which are present in black tea. The Panel considers that the effect of black tea on attention observed in the three human intervention studies provided by the applicant can be explained by its caffeine content. The Panel concludes that a cause and effect relationship has been established between the consumption of black tea and improvement of attention. The Panel considers that the effect of black tea on attention can be explained by its caffeine content. The following wording reflects the scientific evidence: ‘Owing to its caffeine content, black tea improves attention’. In order to obtain the claimed effect, 2–3 servings of black tea providing at least 75 mg of caffeine in total should be consumed within 90 min. |
format | Online Article Text |
id | pubmed-7009616 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70096162020-07-02 Black tea and improvement of attention: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 Turck, Dominique Bresson, Jean‐Louis Burlingame, Barbara Dean, Tara Fairweather‐Tait, Susan Heinonen, Marina Hirsch‐Ernst, Karen Ildico Mangelsdorf, Inge McArdle, Harry J Naska, Androniki Neuhäuser‐Berthold, Monika Nowicka, Grażyna Pentieva, Kristina Sanz, Yolanda Sjödin, Anders Stern, Martin Tomé, Daniel Van Loveren, Henk Vinceti, Marco Willatts, Peter Martin, Ambroise Strain, Sean (JJ) Siani, Alfonso EFSA J Scientific Opinion Following an application from Unilever NV, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Ireland, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to black tea and improvement of attention. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The food proposed by the applicant as the subject of the health claim is black tea. The Panel considers that black tea characterised by its content of tea solids, caffeine and l‐theanine, which is the subject of the health claim, is sufficiently characterised in relation to the claimed effect. The claimed effect proposed by the applicant is ‘improves attention’. The Panel considers that improvement of attention is a beneficial physiological effect. Three human intervention studies provided by the applicant show an effect of black tea on attention under the conditions of used proposed by the applicant. The applicant proposed that the claimed effect depends on the concerted action of two substances, caffeine and l‐theanine, both of which are present in black tea. The Panel considers that the effect of black tea on attention observed in the three human intervention studies provided by the applicant can be explained by its caffeine content. The Panel concludes that a cause and effect relationship has been established between the consumption of black tea and improvement of attention. The Panel considers that the effect of black tea on attention can be explained by its caffeine content. The following wording reflects the scientific evidence: ‘Owing to its caffeine content, black tea improves attention’. In order to obtain the claimed effect, 2–3 servings of black tea providing at least 75 mg of caffeine in total should be consumed within 90 min. John Wiley and Sons Inc. 2018-05-24 /pmc/articles/PMC7009616/ /pubmed/32625903 http://dx.doi.org/10.2903/j.efsa.2018.5266 Text en © 2018 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority. https://creativecommons.org/licenses/by-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ (https://creativecommons.org/licenses/by-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made. |
spellingShingle | Scientific Opinion Turck, Dominique Bresson, Jean‐Louis Burlingame, Barbara Dean, Tara Fairweather‐Tait, Susan Heinonen, Marina Hirsch‐Ernst, Karen Ildico Mangelsdorf, Inge McArdle, Harry J Naska, Androniki Neuhäuser‐Berthold, Monika Nowicka, Grażyna Pentieva, Kristina Sanz, Yolanda Sjödin, Anders Stern, Martin Tomé, Daniel Van Loveren, Henk Vinceti, Marco Willatts, Peter Martin, Ambroise Strain, Sean (JJ) Siani, Alfonso Black tea and improvement of attention: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
title | Black tea and improvement of attention: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
title_full | Black tea and improvement of attention: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
title_fullStr | Black tea and improvement of attention: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
title_full_unstemmed | Black tea and improvement of attention: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
title_short | Black tea and improvement of attention: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
title_sort | black tea and improvement of attention: evaluation of a health claim pursuant to article 13(5) of regulation (ec) no 1924/2006 |
topic | Scientific Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009616/ https://www.ncbi.nlm.nih.gov/pubmed/32625903 http://dx.doi.org/10.2903/j.efsa.2018.5266 |
work_keys_str_mv | AT blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT turckdominique blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT bressonjeanlouis blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT burlingamebarbara blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT deantara blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT fairweathertaitsusan blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT heinonenmarina blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT hirschernstkarenildico blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT mangelsdorfinge blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT mcardleharryj blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT naskaandroniki blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT neuhauserbertholdmonika blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT nowickagrazyna blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT pentievakristina blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT sanzyolanda blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT sjodinanders blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT sternmartin blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT tomedaniel blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT vanloverenhenk blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT vincetimarco blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT willattspeter blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT martinambroise blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT strainseanjj blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 AT sianialfonso blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006 |